RAKIN KEVIN
SEC CIK 1184421 · EDGAR
BoughtSold
Most active insiders at ELUT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RAKIN KEVIN | Dir, 10% | $74.2K | — |
| 2 | NEELS GUIDO J | Dir | $52.6K | — |
| 3 | Ferguson Matthew | CFO | $38.4K | — |
| 4 | HighCape Partners GP II, LLC | 10% | $26.0K | — |
| 5 | Colpman David | Dir | $17.8K | — |
| 6 | Mills C Randal | Pres AND CEO, Dir | $14.6K | — |
| 7 | Makes Brigid | Dir | $13.0K | — |
| 8 | Williams Michelle LeRoux | CSO | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 16:12 | 2026-06-01 | ELUT | ELUTIA INC. | RAKIN KEVIN | Dir, 10% | G - Gift | $0.00 | -70.0K | 126.1K | -36% | $0 | |
| I | 2026-06-02 16:12 | 2026-06-01 | ELUT | ELUTIA INC. | RAKIN KEVIN | Dir, 10% | J - Other | $0.00 | -50.0K | 272.4K | -16% | $0 |
| 2026-02-02 | 2026-01-30 | ELUT | ELUTIA INC. | RAKIN KEVIN | Dir, 10% | P - Purchase | $1.06 | +70.0K | 196.1K | +56% | +$74.2K | |
| AI | 2025-12-17 | 2025-12-11 | ELUT | ELUTIA INC. | RAKIN KEVIN | Dir, 10% | J - Other | — | -4.51M | 4.98M | -48% | — |
| I | 2025-12-15 | 2025-12-11 | ELUT | ELUTIA INC. | RAKIN KEVIN | Dir, 10% | J - Other | — | -4.37M | 4.98M | -47% | — |
| I | 2022-12-22 | 2022-12-20 | QSI | Quantum-Si Inc | RAKIN KEVIN | Dir | J - Other | $0.00 | -601.0K | 1.20M | -33% | $0 |
| I | 2022-12-16 | 2022-12-15 | QSI | Quantum-Si Inc | RAKIN KEVIN | Dir | S - Sale | $2.15 | -89.0K | 1.80M | -5% | -$191.3K |
| 2022-03-22 | 2022-03-21 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | S - Sale | $9.41 | -10.0K | 46.7K | -18% | -$94.1K | |
| D | 2022-02-22 | 2022-02-17 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | M - OptEx | $4.80 | +6,667 | 59.7K | +13% | +$32.0K |
| D | 2022-02-22 | 2022-02-17 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | F - Tax | $10.63 | -3,010 | 56.7K | -5% | -$32.0K |
| A | 2022-02-15 | 2022-02-11 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | G - Gift | $0.00 | -5,000 | 53.0K | -9% | $0 |
| 2022-02-14 | 2022-02-11 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | G - Gift | $0.00 | -5,000 | 47.0K | -10% | $0 | |
| D | 2022-01-05 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | A - Grant | — | +6,000 | 58.0K | +12% | — |
| 2021-12-17 | 2021-12-16 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | G - Gift | $0.00 | -5,000 | 52.0K | -9% | $0 | |
| 2021-09-20 | 2021-09-16 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | S - Sale | $20.99 | -21.1K | 57.0K | -27% | -$442.9K | |
| 2021-09-02 | 2021-08-31 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | A - Grant | — | +10.0K | 78.1K | +15% | — | |
| DM | 2021-08-11 | 2021-08-09 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | F - Tax | $21.09 | -26.1K | 19.1K | -58% | -$550.3K |
| DM | 2021-08-11 | 2021-08-09 | ORMP | ORAMED PHARMACEUTICALS INC. | RAKIN KEVIN | Dir | M - OptEx | $6.95 | +79.1K | 34.2K | New | +$550.3K |
Purchase Sale Sale after option exercise All abbreviations